Literature DB >> 5539006

Erythroplasia of Queyrat: repor. of a patient successfully treated with topical 5-fluorouracil.

R J Lewis, B J Bendl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5539006      PMCID： PMC1930773     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  SELECTIVE CYTOTOXIC EFFECT OF TOPICAL 5-FLUOROURACIL.

Authors:  C J DILLAHA; G T JANSEN; W M HONEYCUTT; A C BRADFORD
Journal:  Arch Dermatol       Date:  1963-09

2.  Further studies with topical 5-fluorouracil.

Authors:  C J Dillaha; G T Jansen; W M Honeycutt; G A Holt
Journal:  Arch Dermatol       Date:  1965-10

3.  Bowenoid conditions of the skin: treatment with topical 5-fluorouracil.

Authors:  G T Jansen; C J Dillaha; W M Honeycutt
Journal:  South Med J       Date:  1967-02       Impact factor: 0.954
  3 in total
  3 in total

1.  Treatment of superficial malignancies with topical 5-Fluorouracil.

Authors:  T Chan
Journal:  Calif Med       Date:  1972-06

2.  Some newer approaches to the treatment of the mucosa of patients with superficial bladder cancer: 1. Continuous bladder irrigation with 5-fluorouracil.

Authors:  J G Connolly; C Anderson; I Johnson
Journal:  Can Med Assoc J       Date:  1979-08-04       Impact factor: 8.262

Review 3.  Penile-sparing modalities in the management of low-stage penile cancer.

Authors:  Paurush Babbar; Nitin Yerram; Alice Crane; Daniel Sun; Kyle Ericson; Andrew Sun; Abhinav Khanna; Hadley Wood; Andrew Stephenson; Kenneth Angermeier
Journal:  Urol Ann       Date:  2018 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.